June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Dry eye and Changes in Driving Habits: The Salisbury Eye Evaluation
Author Affiliations & Notes
  • Jamie Brown
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
  • Esen Akpek
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
  • Suzanne van Landingham
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
  • Sheila West
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
    Dana Center for Preventive Ophthalmology, Baltimore, MD
  • Beatriz Munoz
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
    Dana Center for Preventive Ophthalmology, Baltimore, MD
  • Pradeep Ramulu
    Johns Hopkins Wilmer Eye Institute, Baltimore, MD
    Dana Center for Preventive Ophthalmology, Baltimore, MD
  • Footnotes
    Commercial Relationships Jamie Brown, None; Esen Akpek, Alcon (F), Allergan (F), Baush & Lomb (C); Suzanne van Landingham, None; Sheila West, None; Beatriz Munoz, None; Pradeep Ramulu, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5310. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jamie Brown, Esen Akpek, Suzanne van Landingham, Sheila West, Beatriz Munoz, Pradeep Ramulu; Dry eye and Changes in Driving Habits: The Salisbury Eye Evaluation. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5310.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the association between dry eye symptoms (DES) and clinically significant dry eye (CSDE) with self-reported driving limitations.

 
Methods
 

A population-based sample of 1,896 current or previous drivers (ages 65 to 84), with visual acuity better than 20/40 and no significant visual field loss, were asked if they had driven: (1) at all in the last year, (2) at least 3000 miles in the last year, (3) at night in the last 3 months, or (4) in unfamiliar areas over the last 3 months. DES were defined as one or more self-reported dry eye symptom occurring often or always, while CSDE was defined as the presence of DES plus clinical evidence of dry eye based on Schirmer’s or rose bengal staining. Associations between DES and CSDE with driving cessation and driving restrictions were assessed in multivariable models adjusting for demographic, visual, and health-related factors.

 
Results
 

From the eligible subjects, 275 (11%) had DES and 92 (4%) had CSDE. Univariate analysis showed that subjects with DES, compared to subjects without DES, were more likely to cease driving (14.3% vs. 8.0%, p=0.001), to drive <3000 miles/year (36.5% vs. 26.8%, p=0.002), to not drive at night (26.2% vs. 20.1, p=0.03), but were not more likely to avoid driving in unfamiliar areas (51.7% vs. 50.4%, p=0.7). Subjects with CSDE, compared to subjects without CSDE, trended toward higher likelihood of driving cessation (14.5% vs. 8.6%, p=0.09), but not driving limitations (p>0.19 for all). Multivariable analysis demonstrated that the presence of DES was associated with a 1.8-fold greater odds of driving cessation (95% CI=1.2-2.9; p=0.008) and a greater likelihood of driving less than 3000 miles per year (Odds Ratio [OR]=1.6; 95% CI=1.1-2.2; p=0.007). Subjects with CSDE had a 2.4-fold greater odds of driving cessation when compared with subjects without any signs or symptoms (95% CI=1.1-5.1; p=0.02). Neither DES nor CSDE was significantly associated with the other driving limitations (p>0.13 for all).

 
Conclusions
 

Assessment and treatment of dry eye may prevent significant changes in driving habits or driving cessation, ultimately with improvement of independence and quality of life.

 
 
Percent of subjects who ceased driving, stratified by the number of dry eye symptoms(DES)
 
Percent of subjects who ceased driving, stratified by the number of dry eye symptoms(DES)
 
Keywords: 414 aging: visual performance • 669 quality of life • 459 clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×